View Full Paper

Owner Consent Verified
Policy Brief 4.9

Privacy And Security in Digital Identity for Pharmaceutical Firms: 2020–2029 Trends

8
Pages
MLA
Style
~ 8–12 mins
Reading Time
BioMed Metaverse Risk
Abstract

This policy brief investigates “Privacy And Security in Digital Identity for Pharmaceutical Firms: 2020–2029 Trends” using a difference-in-differences analysis. Through a socio-technical lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

Privacy And Security in Digital Identity for Pharmaceutical Firms: 2020–2029 Trends

ABSTRACT
Privacy And Security in Digital Identity for Pharmaceutical Firms: 2020–2029 Trends is unpacked across themes: equity, change enablement, security, and ethics. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
32 Pages 4.4
Energy Storage for Urban Households: Operational Excellence | Post-Pandemic Lessons
Marketing DevSecOps Cloud
View Paper
35 Pages 4.7
Battery Recycling and Privacy And Security among City Planners — Post-Pandemic Lessons
InsurTech AR/VR Telemedicine
View Paper
22 Pages 4.5
Operational Excellence in Internet of Things for EU Startups: A Comparative Perspective
Risk DevSecOps Education
View Paper